Omnipod Recalled Due to Possibility of High Failure Rate

  • Aug 2015

Insulet Corporation has announced a voluntary recall of 40,846 boxes of the OmniPod (Pod) Insulin Management System due to the possibility that some Pods may have a higher rate of failure than current manufacturing standards.

This recall is a result of the cannula failing to fully deploy or completely retract which may result in the patient not receiving the intended dose. The Pod may also trigger an alarm indicating that it will no longer deliver insulin and need to be replaced.

The affected Pods were distributed from December 2013 to March 2015. The U.S. Food and Drug Administration has posted a list of the Pod lots that have been recalled. The lot number can be found on the Pod tray lid label or on the side of each individual Pod. Please note that this recall does not affect the OmniPod Personal Diabetes Manager.

For a list of recalled products, click here.

You may also like

  • Circulating microRNAs Likely as Effective as A1C for Predicting Type 2 Diabetes in Youth

    Measuring the circulating abundance of microRNAs is likely as effective as measuring the level of sugar in the blood for determining how a young person with the condition will fare, according to a study recently published in The Journal of Clinical Endocrinology & Metabolism. Researchers led by Jeanie Tryggestad, MD, an associate professor of pediatrics…

  • Two Medication Classes Reduced Cardiovascular and Liver Events in People with Type 2 Diabetes

    GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according to data presented at ENDO 2024. Researchers reviewed Medicare data documented from 2013 to 2020 and a large U.S. health insurance database from 2013 to 2022. They performed…

Find more in